Twenty-eight Rahway 7th and 8th Grade Academy were nominated ... If you purchase a product or register for an account through a link on our site, we may receive compensation.

Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA This news release ... available at the SEC’s Internet site (www.sec.gov). These companies largely earn their competitive ...

a subsidiary of Merck & Co., Inc., Rahway, NJ, USA) on two vaccine candidates for infectious diseases entered in September 2024. The projects are tracking according to the agreed plans towards ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its first-quarter 2025 sales and earnings conference call with institutional ...

Night - Cloudy with a 47% chance of precipitation. Winds NW at 15 to 16 mph (24.1 to 25.7 kph). The overnight low will be 50 °F (10 °C). Sunny with a high of 58 °F (14.4 °C) and a 34% chance ...

In a major collaboration with First Nations peoples, from today the tech giant’s Maps product will display more than 250 dual place names for cities and towns across both countries, land borders ...

Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Rahway, New Jersey 07065, United States Analytical Research & Development, Merck & Co., Inc., Rahway ...

New biomarker and immune data from the ongoing phase 2 trial with EVX-01 will be presented at the American Association for Cancer Research (AACR) Annual Meeting These data will further add to the ...

RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (MRK), known as MSD outside of the United States and Canada, and Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”), a global pharmaceutical ...

Merck & Co. is handing over $200 million to China’s Hengrui Pharma for a phase 2-stage lipoprotein(a) (Lp(a)) inhibitor. In return for the ex-China rights to the drug, dubbed HRS-5346, Merck has ...

(Reuters) -Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, the latest in a series of deals U.S. drugmakers have ...

Merck was one of the pioneers of the cholesterol-lowering statins that launched in the 1980s and 1990s and changed medical practice. But it hasn’t been as successful with cholesterol medicines since ...